AlphaYouMB
Insider selling
Matthew Bowen sold $137 of Monte Rosa Therapeutics, Inc. (GLUE) stock
Matthew Bowen, Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE), sold 13 shares of GLUE stock worth $137, per an SEC Form 4 filed Oct 6, 2026.
It was an open-market sale.
The trade happened on Oct 5, 2026, 1 day before it was made public.
GLUE has moved -3.9% since the trade date, from $10.27 to $9.87 (Oct 6, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 1 day
- Price since
- -3.9%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4
More GLUE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.